Khalid Al-Waili

发表

Impact of metabolic syndrome on lipid target achievements in the Arabian Gulf: findings from the CEPHEUS study

I. Al-Zakwani, R. Santos, F. Baslaib, 2016, Diabetology & Metabolic Syndrome.

Consensus clinical recommendations for the management of plasma lipid disorders in the Middle East: 2021 update.

M. Zubaid, W. Almahmeed, K. Sulaiman, 2021, Atherosclerosis.

Sampling time and indications appropriateness for therapeutically monitored drugs at a teaching university hospital in Oman

Khalid Al-Waili, M. Al Za’abi, Juhina Al Muqbali, 2014, Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society.

Comparison of treatment of severe high-density lipoprotein cholesterol deficiency in men with daily atorvastatin (20 mg) versus fenofibrate (200 mg) versus extended-release niacin (2 g).

Z. Awan, J. Genest, I. Ruel, 2008, The American journal of cardiology.

Genetic Lipoprotein Disorders and Cardiovascular Disease

I. Iatan, Z. Dastani, Z. Awan, 2010 .

Non-high-density lipoprotein cholesterol target achievement in patients on lipid-lowering drugs and stratified by triglyceride levels in the Arabian Gulf.

I. Al-Zakwani, R. Santos, F. Baslaib, 2016, Journal of clinical lipidology.

Successful Direct Adsorption of Lipoproteins (DALI) Apheresis During Pregnancy in an Omani Woman with Homozygous Familial Hypercholesterolemia

I. Al-Zakwani, H. Al-Sabti, K. Al-Rasadi, 2015, The open cardiovascular medicine journal.

Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

G. Francis, Qian Wang, D. Gaudet, 2021, The Lancet.

Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study

G. Francis, R. Hegele, M. Reijman, 2022, The Lancet.

Familial Hypercholesterolemia in the Arabian Gulf Region: Clinical results of the Gulf FH Registry

W. Almahmeed, I. Al-Zakwani, K. Alhabib, 2021, PloS one.

The Effect of Residing Altitude on Levels of High-Density Lipoprotein Cholesterol

R. Bayoumi, K. Al-Rasadi, Yajnavalka Banerjee, 2015, Angiology.

Low-Density Lipoprotein Receptor Gene Mutation Analysis and Structure–Function Correlation in an Omani Arab Family With Familial Hypercholesterolemia

I. Al-Zakwani, H. Al-Sabti, K. Al-Hashmi, 2014, Angiology.

Clinical and Genetic Characteristics of Familial Hypercholesterolemia at Sultan Qaboos University Hospital in Oman

I. Al-Zakwani, H. Al-Sabti, K. Al-Hashmi, 2020, Oman medical journal.

Identification and Treatment of Patients with Homozygous Familial  Hypercholesterolaemia: Information and Recommendations from a  Middle East Advisory Panel

R. Santos, F. Alnouri, K. Al-Rasadi, 2015, Current vascular pharmacology.

New Treatments on the Horizon for Familial Hypercholesterolemia.

K. Al-Rasadi, Khalid Al-Waili, 2017, Oman medical journal.

The Achievement of Non-high-density Lipoprotein Cholesterol Target in Patients with Very High Atherosclerotic Cardiovascular Disease Risk Stratified by Triglyceride Levels Despite Statin-controlled Low-density Lipoprotein Cholesterol

I. Al-Zakwani, F. Baslaib, H. Amin, 2022, Oman medical journal.

A Comprehensive Neuropsychological Study of Familial Hypercholesterolemia and Its Relationship with Psychosocial Functioning: A Biopsychosocial Approach

M. Chan, S. Al-Adawi, K. Al-Rasadi, 2022, Brain sciences.

First Case Report of Familial Hypercholesterolemia in an Omani Family Due to Novel Mutation in the Low-Density Lipoprotein Receptor Gene

I. Al-Zakwani, H. Al-Sabti, K. Al-Hashmi, 2013, Angiology.

Will β-Blockers Live up to the Maxim of Sir James Black, Their Creator?

Yajnavalka Banerjee, K. Al-Rasadi, Khalid Al-Waili, 2012, Angiology.

Drug Evaluation: The Combination of Fenofibrate and Simvastatin for the Treatment of Dyslipidemia: When and for Whom?

M. Banach, D. Mikhailidis, M. Rizzo, 2015 .

The Genetic Spectrum of Familial Hypertriglyceridemia in Oman

F. Zadjali, A. Al-Maawali, A. Al-Mujaini, 2022, Frontiers in Genetics.

Statin of Preference to Treat Dyslipidaemia in Patients with Renal Dysfunction: Cues from (SATURN).

R. Bayoumi, Yajnavalka Banerjee, K. Al-Rasadi, 2012, Sultan Qaboos University medical journal.

The Gulf Familial Hypercholesterolemia Registry (Gulf FH): Design, Rationale and Preliminary Results

W. Almahmeed, I. Al-Zakwani, K. Alhabib, 2019, Current vascular pharmacology.

Familial hypercholesterolemia mutations in the Middle Eastern and North African region: a need for a national registry.

N. Seidah, Z. Awan, A. Zaid, 2015, Journal of clinical lipidology.

Criteria for Diagnosis of Familial Hypercholesterolemia: A Comprehensive Analysis of the Different Guidelines, Appraising their Suitability in the Omani Arab Population.

I. Al-Zakwani, H. Al-Sabti, K. Al-Hashmi, 2014, Oman medical journal.

Mutation in the PCSK9 Gene in Omani Arab Subjects with Autosomal Dominant Hypercholesterolemia and its Effect on PCSK9 Protein Structure.

I. Al-Zakwani, H. Al-Sabti, Karna Shah, 2013, Oman medical journal.

White coat hypertension and masked hypertension among omani patients attending a tertiary hospital for ambulatory blood pressure monitoring.

D. Jaju, M. Al-Abri, H. Al-Sabti, 2015, Oman medical journal.

Metabolic Side Effects of Olanzapine in Patients With Psychotic Disorders in Oman: A Retrospective Cohort Study

I. Al-Zakwani, K. Al-Rasadi, S. Al-Adawi, 2022, Angiology.

Dyslipidaemia in the Middle East: Current status and a call for action.

P. Barter, M. Zubaid, W. Almahmeed, 2016, Atherosclerosis.

Comparison of Therapeutic Lipid Target Achievements Among High-Risk Patients in Oman

I. Al-Zakwani, H. Al-Sabti, K. Al-Hashmi, 2014, Angiology.

Control of Risk Factors for Cardiovascular Disease among Multinational Patient Population in the Arabian Gulf

I. Al-Zakwani, R. Santos, F. Baslaib, 2016, Current vascular pharmacology.